Haemonetics reports first quarter fiscal 2016 revenue of $213 million
Haemonetics reported a GAAP net loss of $0.3 million and a GAAP net loss per share of $0.01 in the quarter. Adjusted net income was $18.0 million and adjusted earnings per share were $0.35, both down 9%. July 27, 2015